Literature DB >> 11950999

Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors.

Hisashi Arase1, Edward S Mocarski, Ann E Campbell, Ann B Hill, Lewis L Lanier.   

Abstract

Natural killer (NK) cells express inhibitory receptors for major histocompatibility complex (MHC) class I antigens, preventing attack against healthy cells. Mouse cytomegalovirus (MCMV) encodes an MHC-like protein (m157) that binds to an inhibitory NK cell receptor in certain MCMV-susceptible mice. In MCMV-resistant mice, this viral protein engages a related activating receptor (Ly49H) and confers host protection. These activating and inhibitory receptors are highly homologous, suggesting the possibility that one evolved from the other in response to selective pressure imposed by the pathogen.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11950999     DOI： 10.1126/science.1070884

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  474 in total

1.  Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1.

Authors:  Marine Champsaur; Joshua N Beilke; Kouetsu Ogasawara; Ulrich H Koszinowski; Stipan Jonjic; Lewis L Lanier
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Stepwise cytoskeletal polarization as a series of checkpoints in innate but not adaptive cytolytic killing.

Authors:  Christoph Wulfing; Bozidar Purtic; Jennifer Klem; John D Schatzle
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-11       Impact factor: 11.205

3.  Genomic analysis of immunity in a Urochordate and the emergence of the vertebrate immune system: "waiting for Godot".

Authors:  Kaoru Azumi; Rosaria De Santis; Anthony De Tomaso; Isidore Rigoutsos; Fumiko Yoshizaki; Maria Rosaria Pinto; Rita Marino; Kazuhito Shida; Makoto Ikeda; Masami Ikeda; Masafumi Arai; Yasuhito Inoue; Toshio Shimizu; Nori Satoh; Daniel S Rokhsar; Louis Du Pasquier; Masanori Kasahara; Masanobu Satake; Masaru Nonaka
Journal:  Immunogenetics       Date:  2003-10-07       Impact factor: 2.846

Review 4.  Structure of the Ly49 family of natural killer (NK) cell receptors and their interaction with MHC class I molecules.

Authors:  Nazzareno Dimasi; Lorenzo Moretta; Roberto Biassoni
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 5.  Innate immune control of HIV.

Authors:  Mary Carrington; Galit Alter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

6.  Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control.

Authors:  Annelise Y Mah; Armin Rashidi; Molly P Keppel; Nermina Saucier; Emily K Moore; Joshua B Alinger; Sandeep K Tripathy; Sandeep K Agarwal; Emily K Jeng; Hing C Wong; Jeffrey S Miller; Todd A Fehniger; Emily M Mace; Anthony R French; Megan A Cooper
Journal:  JCI Insight       Date:  2017-12-07

Review 7.  Memory responses of natural killer cells.

Authors:  Clair D Geary; Joseph C Sun
Journal:  Semin Immunol       Date:  2017-08-30       Impact factor: 11.130

Review 8.  NKT cell immune responses to viral infection.

Authors:  Marlowe S Tessmer; Ayesha Fatima; Christophe Paget; Francois Trottein; Laurent Brossay
Journal:  Expert Opin Ther Targets       Date:  2009-02       Impact factor: 6.902

9.  NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs.

Authors:  Vivien Béziat; Lisa L Liu; Jenny-Ann Malmberg; Martin A Ivarsson; Ebba Sohlberg; Andreas T Björklund; Christelle Retière; Eva Sverremark-Ekström; James Traherne; Per Ljungman; Marie Schaffer; David A Price; John Trowsdale; Jakob Michaëlsson; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

10.  Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells.

Authors:  Valentina Voigt; Catherine A Forbes; Joanne N Tonkin; Mariapia A Degli-Esposti; Hamish R C Smith; Wayne M Yokoyama; Anthony A Scalzo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.